Table 1 Individual risk factors that could suggest a pharmacological VTE prophylaxis

Individual or family history of VTE (first degree relatives)

XX

Known congenital or acquired thrombophilia (Table 2)

XX

Active cancer or cancer treatment

XX

Obesity (BMI >30)

XX

Bed confinement (>3 days)

XX

Impediment to normal ambulation (weight bearing <10–20 kg, lower extremity immobilisation)

X

Age (>60–70 years)

X

Oestrogen contraceptive therapy or hormone replacement surgery (ongoing or within 1 month after suspension)

X

Pregnancy or puerperium (6 weeks after delivery)

X

Recent acute myocardial infarction (AMI) or stroke

X

Chronic heart failure

X

Chronic respiratory failure

X

Inflammatory bowel disease

X

Sepsis or severe infections

X

Large varicose veins

X

Nephrotic syndrome

X